D334DRM Protecta DR
Implantable Cardioverter Defibrillator (ICD)
D334DRM Protecta DR
Information

Device Survival Probability

D3xxDRx_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr 8 yr 9 yr 10 yr 11 yr at 136.0 mo                  
% Excluding Normal Battery Depletion 100.0 99.9 99.9 99.9 99.9 99.8 99.7 99.7 99.6 99.6 99.6 99.6                  
% Including Normal Battery Depletion 99.8 99.7 99.5 99.0 97.2 91.3 77.6 52.8 38.7 37.1 36.5 36.2                  
#   54184 50301 46252 42263 37893 31012 20451 9299 5158 4196 1292 127                  
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Customer Communications For This Model

  • There are no communications for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code DDE-DDDR
Max. Delivered Energy 35 J
More
Connector Style DF4 DR Style
Serial Number Prefix PSM
Mass 73 g
Volume 41 cc
Waveform Biphasic
X-Ray ID PSI
Hide this content
DF4 DR Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.6 4.1 4.5 4.7
Quarterly 5.1 6.0 7.0 7.5
Semi-annual 5.7 7.0 8.3 9.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release2011-11-09
CE Approval Date
Registered USA Implants2997
Estimated Active USA Implants500
Normal Battery Depletions577
US Market Release2011-11-09
CE Approval Date
Estimated WW Distribution3123
Normal Battery Depletions578
Information

Malfunctions (USA)

Therapy Function Not Compromised 0
Therapy Function Compromised 1
Battery 1
Information

Malfunctions (WW)

Therapy Function Not Compromised 0
Therapy Function Compromised 1
Battery 1
Information

EOL Indicator

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.63V on 3 consecutive daily automatic measurments.

Information

Charge Time

D334DRx_D364DRx_CHRG
Loading...

Data as of December 1, 2023

www.medtronic.com/productperformance 951051